A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia

Site JP00008, Aichi

Site JP00018, Aichi

Site JP00020, Aichi

Site JP00032, Aichi

Site JP00033, Aichi

Site JP00040, Aichi

Site JP00004, Ehime

Site JP00055, Ehime

Site JP00009, Fukui

Site JP00059, Fukui

Site JP00014, Fukuoka

Site JP00049, Fukuoka

Site JP00010, Fukushima

Site JP00056, Fukushima

Site JP00057, Fukushima

Site JP00030, Gifu

Site JP00050, Gifu

Site JP00011, Gunma

Site JP00026, Gunma

Site JP00037, Gunma

Site JP00003, Hokkaido

Site JP00031, Hokkaido

Site JP00038, Hokkaido

Site JP00048, Hokkaido

Site JP00017, Ibaraki

Site JP00041, Ibaraki

Site JP00042, Ibaraki

Site JP00045, Ibaraki

Site JP00046, Ibaraki

Site JP00047, Ibaraki

Site JP00054, Ibaraki

Site JP00058, Ibaraki

Site JP00043, Kagoshima

Site JP00005, Kanagawa

Site JP00028, Kumamoto

Site JP00029, Kumamoto

Site JP00006, Kyoto

Site JP00002, Nagano

Site JP00012, Nagano

Site JP00027, Nagano

Site JP00051, Nagano

Site JP00013, Nagasaki

Site JP00001, Niigata

Site JP00034, Niigata

Site JP00036, Okayama

Site JP00007, Osaka

Site JP00015, Osaka

Site JP00016, Saitama

Site JP00035, Saitama

Site JP00044, Tokushima

Site JP00052, Tokyo

Site JP00053, Tokyo

Site JP00021, Toyama

Site JP00022, Toyama

Site JP00039, Toyama

Site JP00024, Yamagata

Site JP00025, Yamaguchi